Role of MMP-2 and CD147 in Kidney Fibrosis
Overview
Affiliations
Matrix metalloproteinase-2 (MMP-2) and cluster of differentiation 147 (CD147) both play important roles in the development of kidney fibrosis, and CD147 can induce the production and activation of MMP-2. In the early stage of kidney fibrosis, MMP-2 promotes extracellular matrix (ECM) production and accelerates the development of kidney fibrosis, while in the advanced stage, MMP-2 activity decreases, leading to reduced ECM degradation and making it difficult to alleviate kidney fibrosis. The reason for the decrease in MMP-2 activity in the advanced stage is still unclear. On the one hand, it may be related to hypoxia and endocytosis, which lead to changes in the expression of MMP-2-related active regulatory molecules; on the other hand, it may be related to insufficient CD147 function. At present, the specific process by which CD147 is involved in the regulation of MMP-2 activity is not completely clear, and further in-depth studies are needed to clarify the roles of both factors in the pathophysiology of kidney fibrosis.
Johnson B, Haritha C, Mathesh K, Vamadevan B, Sharma A, Aneesha V Naunyn Schmiedebergs Arch Pharmacol. 2025; .
PMID: 39820546 DOI: 10.1007/s00210-024-03728-x.
Fibrosis in Chronic Kidney Disease: Pathophysiology and Therapeutic Targets.
Reiss A, Jacob B, Zubair A, Srivastava A, Johnson M, Leon J J Clin Med. 2024; 13(7).
PMID: 38610646 PMC: 11012936. DOI: 10.3390/jcm13071881.
Yakupova E, Semenovich D, Abramicheva P, Zorova L, Pevzner I, Andrianova N Heliyon. 2023; 9(11):e21003.
PMID: 37928038 PMC: 10623167. DOI: 10.1016/j.heliyon.2023.e21003.
Ding L, Liang M, Li Y, Zeng M, Liu M, Ma W Adv Sci (Weinh). 2023; 10(27):e2302967.
PMID: 37439462 PMC: 10520680. DOI: 10.1002/advs.202302967.
Lu X, Wu K, Jiang S, Li Y, Wang Y, Li H Front Pharmacol. 2023; 14:1153503.
PMID: 37266145 PMC: 10229821. DOI: 10.3389/fphar.2023.1153503.